Naproxen-incorporated lipid emulsions III. Anti-inflammatory effect in a rabbit model

S.T.P. Pharma Sciences

Volumn 8, Issue 6, 1998, Pages 379-382

  Nasirideen, S ^a   Kas, H S ^a   Peksoy, I ^a   Ercan, M T ^a   Hascelik Z ^a   Oner F ^a   Hincal, A A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anti inflammatory; Dimethyl sulphoxide; Emulsions; Naproxen; Radiolabelling

Indexed keywords

DIMETHYL SULFOXIDE; LIPID EMULSION; NAPROXEN; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG LABELING; DRUG MIXTURE; EMULSION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; KNEE ARTHRITIS; NONHUMAN; RABBIT;

EID: 0032445793     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. PRANKERD R.J. and STELLA V.J. - The use of oil-in-water emulsions as a vehicle for parenteral drug administration. - J. Parent. Sci. Technol., 44, 139-149, 1990.
2. MEHTA R.C., HEAD L.F., HAZRATI A.M., PARR M., RAPP R.P. and DELUCA P.P. - Fat emulsion particle size distribution in total nutrient admixmitures. - Am. J. Hosp. Pharm., 49, 2749-2755, 1992.
3. CHANANA D.G. and SHETH B.B. - Particle size reduction of emulsions by formulation design. I: Effects of polyhydroxyalcohols. - J. Parent. Sci. Technol., 47, 130-134, 1993.
4. DIEDERICHS J.E., MEHNERT W., LUCKS J.S. and MÜLLER R.H. - Microviscosity measurements for the optimization of liposomes and emulsion formulations. - 6th International Conference on Pharmaceutical Tecnology, Paris, 1992, APGI Ed., Vol. V, pp. 138-147.
5. WESTESEN K. and WEHLER T. - Physicochemical characterization of a model of intravenous oil-in-water emulsions. - J. Pharm. Sci., 81, 777-786, 1992.
6. ANDERSON J.V. and HANSEN S.H. - Simultaneous quantitative determination of naproxen, its metabolite 6-0-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica. - J. Chromatogr., 577, 325-333, 1992.
7. CONFORTI A., BERTANI S., LUSSIGNOLI S., GRIGOLINI L., TERZI M., LORA S., CALCETI P., MARSILIO F. and VERONESE P.M. - Anti-inflammatory activity of polyphosphazene-based naproxen slow release systems - J. Pharm. Pharmacol., 48, 468-473, 1996.
8. NASIREDEEN S., KAS H.S., ÖNER F., ALPAR R. and HINCAL A.A. - Naproxen incorporated lipid emulsions. I: Formulation and stability studies. - J. Clin. Pharm. and Ther., 23, 57-66, 1998.
9. RATCLIFFE J.H., HUNNEYBALL I.M., WILSON C.G., SMITH A. and DAVIS S.S. - Albumin microspheres for intra-articular delivery : Investigation of their retention in normal and arthritic knee joints of rabbits. - J. Pharm. Pharmacol., 39, 290-295, 1987.
10. DAVIS S.S., HADGRAFT J. and PALI N.K.J. - Medical and pharmaceutical applications of emulsions. - In : Encyclopedia of Emulsion Technology, Vol. II, P. Becher Ed., Marcel Dekker Inc., New York, 1985, pp. 159-225.
11. HERMAN C.J. and GROVES M.J. - Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsion formulations. - J. Pharm. Pharmacol., 44, 539-542, 1992.
12. 99m-labelled IgG. - J. Nucl. Med., 30, 2017-2021, 1989.
13. ROSENSPIRE K.L., BLAU H., KENNEDY A.C. and GREEN F.A. - Assessment and interpretation of radiopharmaceuticals: joint imaging in an animal model of arthritis. - Arth. Rheum., 24, 711-716, 1981.
14. CHEN T., LAUSIER J.M. and RHODES C.T. - Possible strategies for the formulation of antineoplastic drugs. - Drug. Dev. Ind. Pharm., 12, 1084-1086, 1986.
15. MIZUSHIMA Y., YANAGAWA A. and HOSHI K. - Prostoglandin E1 is more effective when incorporated in lipid microspheres for the treatment of peripheral diseases in man. - J. Pharm. Pharmacol., 35, 666 -667, 1983.
16. SHOJI Y., MIZUSHIMA Y., YANAGAWA A., SHIBA T., TAKEI H., FUJII M. and AMINO M. - Enhancement of anti-inflammatory effects of biphenylacetic acid by its incorporation into lipid microspheres. - J. Pharm. Pharmacol., 38, 118-121, 1986.